← back to search

Rong Zhou

First Affiliated Hospital of Gannan Medical University · US
Area of research
Radiology, Nuclear Medicine and Imaging · Cancer Research
Research interest
Research interests include Advanced MRI Techniques and Applications, Medical Imaging Techniques and Applications, MRI in cancer diagnosis, and Cancer, Hypoxia, and Metabolism.
h-index
48
citations
7,335
works
222
NIH funding
primary concept
Medicine
email

Recent publications

Imaging from Macro to Nanoscale: Multimodal Advances in Chemical and Biomedical Imaging
Chemical & Biomedical Imaging 2026cited by 0position: contributordoi
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export
Neoplasia 2025cited by 6position: contributordoi
Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy.
2025cited by 4position: contributordoi
Natural and Synthetic LDL-Based Imaging Probes for the Detection of Atherosclerotic Plaques.
2025cited by 2position: contributordoi
MRI Detection of PDAC Response to KRAS Inhibitor Therapy-Response.
2025cited by 0position: contributordoi
Supplementary Table S1 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Supplementary Data S1 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Supplementary Figure S8 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Data from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Supplementary Figure S3 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Supplementary Figure S4 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Supplementary Figure S2 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Supplementary Figure S5 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Modeling tumor dynamics and predicting response to chemo-, targeted-, and immune-therapies in a murine model of pancreatic cancer
2025cited by 0position: contributordoi
Supplementary Figure S7 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Supplementary Figure S1 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Supplementary Figure S6 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025cited by 0position: contributordoi
Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2024cited by 1position: contributordoi
Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study
2024cited by 0position: contributordoi
Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Orthotopic Mouse Model of Pancreatic Cancer.
2023cited by 5position: contributordoi
Evaluation of Apparent Diffusion Coefficient Repeatability and Reproducibility for Preclinical MRIs Using Standardized Procedures and a Diffusion-Weighted Imaging Phantom.
2023cited by 5position: contributordoi
Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials.
2023cited by 5position: contributordoi
Co-Clinical Imaging Metadata Information (CIMI) for Cancer Research to Promote Open Science, Standardization, and Reproducibility in Preclinical Imaging.
2023cited by 5position: contributordoi
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutamate export and glutaminase
2023cited by 5position: contributordoi
DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models.
2022cited by 13position: contributordoi
Improving Cancer Detection and Treatment by pH‐Sensitive Peptide Nanoparticle Drug Delivery Platform: Pharmacokinetics, Toxicity, and Immunogenicity Profile
Advanced NanoBiomed Research 2022cited by 1position: contributordoi
Processing Stack-of-Stars DCE Data v1
2022cited by 0position: contributordoi
Respiratory Motion Mitigation and Repeatability of Two Diffusion-Weighted MRI Methods Applied to a Murine Model of Spontaneous Pancreatic Cancer.
2021cited by 7position: contributordoi
Improving Cancer Detection and Treatment by pH‐Sensitive Peptide Nanoparticle Drug Delivery Platform: Pharmacokinetics, Toxicity, and Immunogenicity Profile
Advanced NanoBiomed Research 2021cited by 4position: contributordoi
LDL-mimetic lipid nanoparticles prepared by surface KAT ligation for <i>in vivo</i> MRI of atherosclerosis.
2020cited by 18position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 30 papers (2020–2026)Hoon Choi · University of Pennsylvania14 papers (2023–2025)Emma E. Furth · Cancer Research Center14 papers (2022–2025)Quy Cao · California University of Pennsylvania13 papers (2022–2025) · 13 papers (2025–2025)Ben Z Stanger · Abramson Cancer Center13 papers (2024–2025)Mamta Gupta · NYU Langone Health13 papers (2022–2025) · 12 papers (2025–2025)Mark Rosen · University of Pennsylvania12 papers (2025–2025)Stephen Pickup · University of Pennsylvania12 papers (2025–2025)Margo Orlen · California University of Pennsylvania12 papers (2025–2025)Fang Liu · University of Pennsylvania12 papers (2025–2025)Cynthia Clendenin · La Jolla Alcohol Research12 papers (2025–2025)Michael T. Lewis · Clark Atlanta University3 papers (2023–2023)Renuka Sriram · University of California, San Francisco3 papers (2023–2023)Thomas E. Yankeelov · Livestrong Foundation2 papers (2023–2025)Robia G. Pautler · Elsevier, Inc.2 papers (2023–2023)Yoko Yamakoshi · ETH Zurich2 papers (2020–2025)Seth T. Gammon · Carestream (United States)2 papers (2023–2023)Naoko Yoshizawa-Sugata · Ochanomizu University2 papers (2020–2025)